This notion indicated that PLS-123′s great efficacy and anti-proliferative effects in GCB-DLBCL lymphoma might not only be simply attributed to downregulation of BCR signaling pathway alone and alternative selectivity profile provided downregulation of PTPN11 expression should also be considered. Here, BCR is linked to diffuse large B-cell lymphoma.